Developing a Patient-Centered Model of Prostate Cancer Care: Patient Satisfaction With a Survivorship Program Embedded in Urologic-Oncologic Care - 22/02/22
, C. Varlamos 1, N. Rodriguez-Galano 1, L. Day 1, G Grube 1, J. Shifferd 1, K Erickson 1, A. Duby 1, T.M. Morgan 1, B.K. Hollenbeck 1, T.A. Skolarus 1, 2, S.S. Salami 1, S.D. Kaffenberger 1, J.E. Montie 1Abstract |
Objective |
To evaluate patients’ and partners’ satisfaction with a prostate cancer survivorship program embedded in urologic-oncologic care. As a part of quality improvement activity, we developed a patient and partner-centered, biopsychosocial support program for men and partners coping with the urinary and sexual side-effects of surgical treatment for prostate cancer. The program became a part of usual care for all prostate cancer patients.
Methods |
Patients who saw both an advanced practice provider and a sex therapist between August 1, 2018 and July 31, 2019 were eligible. Surveys packets were sent to 146 patients with surveys included for partners (N = 292). We used descriptive statistics to characterize participant responses.
Results |
Responses were received from 88 patients and 70 partners (56% response rate for the group). Patients and partners reported very high or fairly high satisfaction with the rehabilitation activities of the program (86-97% and 90%-100%, respectively); 91% of patients and 84% of partners thought having pre-operative education and post-operative rehabilitation was a good or fairly good idea; 83% of patients and 79% of partners would very much or somewhat recommend the program to a friend who was considering surgical treatment for prostate cancer.
Conclusion |
Embedding a patient and partner-centered prostate cancer survivorship support program in oncologic care can positively impact patients’ and partners’ engagement in and satisfaction with post-operative rehabilitation.
Le texte complet de cet article est disponible en PDF.Abbreviations : ED, PCa, PSA, BPCSP
Plan
| Disclosures: Dr, Wittmann is Associate Editor for Journal of Sexual Medicine (Elsevier) and on the Board of Directors of the Sexual Medicine Society of North America; a portion of Dr. Wittmann's salary is paid by the University of Michigan Department of Urology's Brandon Survivorship Fund. Dr. Morgan is Associate Editor for European Urology (Elsevier). Dr. Hollenbeck is Associate Editor for UROLOGY (Elsevier). Dr. Skolarus receives royalties for a section on prostate cancer survivorship from UpToDate and grant funding (NCI R37CA222885 and 1R01CA242559) from the National Institutes of Health. Dr. Montie has salary support from Blue Cross Blue Shield of Michigan and from the Michigan Urological Surgery Improvement Collaborative. |
|
| All other authors have no disclosures. |
Vol 160
P. 161-167 - février 2022 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
